Non-Oxidised Parathyroid Hormone and a Panel of Markers of Calcium–Phosphate Metabolism for Analysis of Secondary Hyperparathyroidism in Selected Patient Groups—A Quality Assurance Project
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094279 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ursula Huber-Schoenauer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University, A-5020 Salzburg, Austria. Hauptthemen laut MEDLINE: Parathyroid Hormone, Hyperparathyroidism, Secondary, Biomarkers, Phosphates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intact parathyroid hormone (PTHi) plays a central role in the regulation of mineral and bone metabolism. Due to post-translational modifications of the hormone, the interpretation of elevated PTHi values is challenging and may benefit from an expanded analytical panel. Within this project, additional parameters of calcium–phosphate metabolism, such as non-oxidised parathyroid hormone (noxPTH), calcidiol, vitamin D binding protein (VDBP), and fibroblast growth factor 23 (FGF23) were evaluated in a control population of 177 individuals as well as 182 patients with renal, gastroenterological, and liver diseases. While PTHi and noxPTH levels were up to 10-fold higher in dialysis patients, the proportion of noxPTH on PTHi was significantly higher for all patient groups showing signs of inflammation. However, no strong confounders for PTHi could be identified. The correlation between CRP and the proportion of oxidised PTHi in total PTHi suggests an influence of inflammatory oxidative stress on the proportion of active noxPTH. Apart from the established role of vitamin D, the addition of noxPTH and its proportion of total PTHi in the assessment of unclear PTHi elevations seems reasonable, whereas there is no evidence for the standardised analysis of further parameters such as FGF23 and VDBP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University, A-5020 Salzburg, Austria.
- Department of Laboratory Medicine, Paracelsus Medical University, A-5020 Salzburg, Austria.
- Independent Researcher, Landstraße 243, A-5424 Bad Vigaun, Austria.
- Salzburg University of Applied Sciences, A-5412 Salzburg, Austria.
- Department of Internal Medicine II, Paracelsus Medical University, A-5020 Salzburg, Austria.
- Department of Internal Medicine I, Paracelsus Medical University, A-5020 Salzburg, Austria.
ORCID-Profile: Ursula Huber-Schoenauer, Janne Cadamuro, Vera Paar, Christian Pirich, Hermann Salmhofer
Zitieren
APA
Huber-Schoenauer, U., Cadamuro, J., Kipman, U., Stoellinger, E., Lichtenauer, M., Paar, V., Kedenko, L., Guggenbichler, K., Paulweber, B., Pirich, C., & Salmhofer, H. (2025). Non-Oxidised Parathyroid Hormone and a Panel of Markers of Calcium–Phosphate Metabolism for Analysis of Secondary Hyperparathyroidism in Selected Patient Groups—A Quality Assurance Project. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094279
Vancouver
Huber-Schoenauer U, Cadamuro J, Kipman U, Stoellinger E, Lichtenauer M, Paar V, et al. Non-Oxidised Parathyroid Hormone and a Panel of Markers of Calcium–Phosphate Metabolism for Analysis of Secondary Hyperparathyroidism in Selected Patient Groups—A Quality Assurance Project. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094279
BibTeX
@article{HuberSchoenauer2025,
author = {Huber-Schoenauer, Ursula and Cadamuro, Janne and Kipman, Ulrike and Stoellinger, Emma and Lichtenauer, Michael and Paar, Vera and Kedenko, Ludmilla and Guggenbichler, Kathrin and Paulweber, Bernhard and Pirich, Christian and Salmhofer, Hermann},
title = {Non-Oxidised Parathyroid Hormone and a Panel of Markers of Calcium–Phosphate Metabolism for Analysis of Secondary Hyperparathyroidism in Selected Patient Groups—A Quality Assurance Project},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094279}
}
EUVIMED